Fund moves

Danaher Corporation (DHR): Perceptive Advisors LLC exited its position 200K shares

Perceptive Advisors LLC exited its position in Danaher Corporation, per its Q1 2026 13F.

200K
Prior-quarter shares · no longer reported
Holdings as of
Mar 31, 2026
Filed
May 29, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
  2. Apr 16, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  3. Apr 21, 2026Company filing · Form 8-K · ResultsReported its results
  4. Apr 22, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  5. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.7%
  6. May 1, 2026InsiderDirector sold ~$237K of DHR shares in the open market
  7. May 5, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 5, 2026, at the annual meeting of shareholders (the “Annual Meeting”) of Danaher Corporation (the “Company”), as further described in Item 5.07 below, the Company’s shareholders approved the Amended and Restated Danaher Corporation Omnibus Incentive Plan (the “Plan”).”

What came next

  1. Jun 3, 2026Company filing · Form 8-K · New debt, Other newsTook on new debt or obligations, and reported other company news
  2. Jul 15, 2026FDARecall: Beckman Coulter DxC 500 AU Clinical Analyzer Modules using software version 1.5 or lower: 1) AU w/out ISE, Part Number C63519; 2) AU w/ISE, Part Number C63520;…
  3. Jul 15, 2026FDARecall: Beckman Coulter DxC 500i Clinical Analyzer Modules using software version 1.5 or lower: 1) DxC 500 AU Module w/ISE, DxC 500i, Part Number C63522; 2) DxC 500 AU…
  4. Jul 21, 2026Company filing · Form 8-K · ResultsReported its results
  5. Jul 31, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors (and 1 more item)“On August 3, 2026, Danaher Corporation (the “Company” or “Danaher”) announced that, effective as of October 1, 2026 (the “Effective Date”), the Board of Directors of the Company (the “Board”) has appointed Julie Sawyer Montgomery as President and Chief Executive Officer of the Company (the “CEO”).”
  6. Aug 3, 2026FDARecall: Systems/units containing affected software/SQL BECKMAN COULTER CHEMISTRY ANALYZER AU480 REF / UDI-DI code: B96692 / 14987666542965 B96693 / 14987666542972 B121…
  7. Aug 7, 2026FDAFDA device clearance: Xpert Hemorrhagic Fever
  8. Aug 7, 2026FDAFDA device clearance: Aperio iQC DX Software
  9. Aug 7, 2026FDAFDA device clearance: Aperio GT 450 DX; Aperio GT 180 DX
  10. Aug 12, 2026FDARecall: DxU 840m Iris, REF: C76947; DxU 850m Iris, REF: C49513
  11. Aug 12, 2026FDARecall: IQ200 SPRINT, REF: 700-3322,700-3322RFB, 700-3325, 700-3326, B48997; IQ200 SELECT, REF: 700-3340, 700-3345, 700-3347, B48998, C10684; IQ200 ELITE, REF: 700-337…
  12. Aug 18, 2026FDARecall: The ABL90 FLEX and ABL90 FLEX PLUS analyzers are intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a labo…
  13. Aug 21, 2026Insider · 1 personInsiders: 3 sales (~$12.7M)
  14. Aug 31, 2026CongressDisclosed sale of DHR — reported range $15,001 - $50,000
  15. Sep 2, 2026FDARecall: DxC 500 AU Clinical Chemistry Analyzers: 1. AU w/out ISE, Part No. C63519 2. AU w/ISE, Part No. C63520
  16. Sep 2, 2026FDARecall: DxC 500i Clinical Analyzer Modules: 1. DxC 500 AU Module w/ISE, DxC 500i, Part No. C63522 2. DxC 500 AU Module, DxC 500i, Part No. C63521 3. Access 2 Module, D…
  17. Sep 2, 2026CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
  18. Sep 21, 2026FDAFDA device clearance: Access NT-proBNP
  19. Sep 21, 2026FDARecall: ROTOR ASSY-SW41, Reference Number 331362, when the rotors are installed in the following centrifuges: Optima XPN-100 (Model Numbers A99846 and A94469), Optima…
  20. Sep 21, 2026FDARecall: ROTOR ASSY-SW40, Reference Number 331302, when the rotors are installed in the following centrifuges: Optima XPN-100 (Model Numbers A99846 and A94469), Optima…
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

How this filing works

Explore the data

Common questions

What does this filing report about Danaher Corporation (DHR) stock?

Perceptive Advisors LLC exited its position in Danaher Corporation, per its Q1 2026 13F. Held the prior quarter, no longer listed per its Q1 2026 13F.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2026. Filed: May 29, 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Danaher Corporation recently?

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 7 fund holdings reports (13F) dated in the last 90 days. They are listed on the DHR page.

Does this mean DHR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Danaher Corporation

Everything OQRO holds on this company is on its DHR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data